Actemra Prices, Coupons, Copay Cards & Patient Assistance
Actemra (tocilizumab) is a member of the interleukin inhibitors drug class and is commonly used for COVID-19, Cytokine Release Syndrome, Giant Cell Arteritis, and others.
Actemra prices
Intravenous Solution
20 mg/mL Actemra intravenous solution from $526.74 for 4 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 4 milliliters | $131.69 | $526.74 |
| 10 milliliters | $130.50 | $1,305.00 |
| 20 milliliters | $130.11 | $2,602.10 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Subcutaneous Solution
162 mg/0.9 mL Actemra subcutaneous solution from $1,155.45 for 0.9 milliliters
| Brand | Quantity | Per unit | Price |
|---|---|---|---|
| Actemra | 0.9 milliliters | $1,283.83 | $1,155.45 |
| Actemra ACTPen | 0.9 milliliters | $1,283.83 | $1,155.45 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Actemra Coupons, Copay Cards and Rebates
Actemra offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Actemra Co-pay Card Program
Eligible commercially insured patients may pay $5 per prescription with savings of up to $15,000 per calendar year.
- Applies to:
- Actemra
- Number of uses:
- Per prescription per calendar year
Form more information phone: 855-722-6729 or Visit website
Actemra Co-pay Card Program Rebate
Eligible commercially insured patients may submit a rebate request if they paid out-of-pocket for their prescription.
- Applies to:
- Actemra
- Number of uses:
- One rebate per prescription fill
Form more information phone: 855-722-6729 or Visit website
Patient Assistance & Copay Programs for Actemra
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Actemra (tocilizumab) Injection
- Actemra ACTPen (tocilizumab) Injection; Subcutaneous
More information please phone: 800-675-8416 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Actemra (tocilizumab) Injection
More information please phone: 866-316-7263 Visit website
Provider: Genentech Patient Foundation
Eligibility requirements:- Uninsured or Underinsured with no prescription coverage for needed medication
- Based on FPL
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Actemra (tocilizumab) Injection
More information please phone: 888-941-3331 or 866-422-2377 Visit website
Provider: Genentech Access Solutions: Actemra & Rituxan
Eligibility requirements:- Determined case by case
- Based on FPL
- Varies
- Must be treated by US licensed healthcare provider
- Eligibility determined on a case-by-case basis. Contact program for details. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Actemra (tocilizumab) Injection
More information please phone: 866-681-3261 or 866-422-2377 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Rinvoq
Rinvoq is used to treat rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative ...
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Tyenne
Tyenne is approved to treat adults with moderately to severely active rheumatoid arthritis, Giant ...
Rayos
Rayos (prednisone, delayed-release) is used to treat rheumatoid arthritis, polymyalgia rheumatica ...
Sterapred
Sterapred is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Tofidence
Tofidence (tocilizumab-bavi) is administered as an intravenous infusion by a healthcare provider ...
Prednicot
Prednicot is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Upadacitinib
Upadacitinib is an oral Janus kinase (JAK) inhibitor that may be used alone or in combination with ...
Prednisone
Prednisone is used to treat allergic disorders, ulcerative colitis, psoriasis and arthritis. Learn ...
More about Actemra (tocilizumab)
- Check interactions
- Compare alternatives
- Reviews (49)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español